Upadacitinib, Upadacitinib matching placebo clinical trials

A Phase 3 Randomized, Placebo-Controlled, Double-Blind Program to Evaluate Efficacy and Safety of Upadacitinib in Adult Subjects with Axial Spondyloarthritis Followed by a Remission-Withdrawal Period

This study is testing a new medicine, Upadacitinib, for adults with a type of arthritis called axial spondyloarthritis. It's comparing the medicine to a dummy pill to see if it helps reduce pain and stiffness, and if it's safe to use.